Reinvention starts here

doi:10.1136/bmj.327.7422.0-g

BMJ 2003;327 (1 November), doi:10.1136/bmj.327.7422.0-g

Editor's choice

Reinvention starts here

The first 150 words of the full text of this article appear below.

If anyone doubts that academic medicine needs all the supportit can get then articles in this week's journal should convincethem. The centrepiece is a report from the Academy of MedicalSciences on the woeful state of clinical research in the UnitedKingdom (p 1041).

Some of the problems relate to funding. But what's more corrosivethan lack of money is the apparent abandonment of the beliefin the value of academic medicine. The full explanation of thisfall from grace is unclear, but Jocalyn Clark and Richard Smithprovide some clues in their editorial (p 1001). This may bethe right time to ascertain what the world wants from academicmedicine and then set about finding the best ways to deliverit. Firstly, however, the world will need to be reminded ofthe benefits that academic medicine has already delivered.

In a paper providing . . . [Full text of this article]

Tony Delamothe, web editor

(tdelamothe@bmj.com)

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

Technorati What's this?

Relevant Articles

BMJ Publishing Group to launch an international campaign to promote academic medicine: Jocalyn Clark and Richard Smith
BMJ 2003 327: 1001-1002. [Extract] [Full Text] [PDF]

Cochrane plans to allay fears over industry influence: Ray Moynihan
BMJ 2003 327: 1005. [Extract] [Full Text] [PDF]

Lancet accuses AstraZeneca of sponsoring biased research: Owen Dyer
BMJ 2003 327: 1005. [Extract] [Full Text] [PDF]

Industry sponsored studies twice as likely to have positive conclusions about costs: Roger Dobson
BMJ 2003 327: 1006. [Extract] [Full Text] [PDF]

Descriptive survey of non-commercial randomised controlled trials in the United Kingdom, 1980-2002: Iain Chalmers, Cath Rounding, and Kate Lock
BMJ 2003 327: 1017. [Abstract] [Full Text] [PDF]